UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 210

Sortiert nach

Unintended consequences of evolution of the Common Terminology Criteria for Adverse Events

Pediatric blood & cancer, 2019-07, Vol.66 (7), p.e27747-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Leveraging machine learning to identify acute myeloid leukemia patients and their chemotherapy regimens in an administrative database

Pediatric blood & cancer, 2023-05, Vol.70 (5), p.e30260-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Using electronic medical record data to report laboratory adverse events

British journal of haematology, 2017-04, Vol.177 (2), p.283-286

2017

Link zum Volltext

Verfügbarkeit prüfen

A report from the Leukemia Electronic Abstraction of Records Network on risk of hepatotoxicity during pediatric acute lymphoblastic leukemia treatment

Haematologica (Roma), 2022-05, Vol.107 (5), p.1185

2022

Link zum Volltext

Verfügbarkeit prüfen

Data standards in pediatric oncology: Past, present, and future

Pediatric blood & cancer, 2023-02, Vol.70 (2), p.e30128-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemia

PloS one, 2018-02, Vol.13 (2), p.e0192529-e0192529

2018

Link zum Volltext

Verfügbarkeit prüfen

Supportive Care in Pediatric Oncology: Opportunities and Future Directions

Cancers, 2023-11, Vol.15 (23), p.5549

2023

Link zum Volltext

Verfügbarkeit prüfen

An Interpretable Machine Learning Framework for Rare Disease: A Case Study to Stratify Infection Risk in Pediatric Leukemia

Journal of clinical medicine, 2024-03, Vol.13 (6), p.1788

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical covariates that improve the description of high dose methotrexate pharmacokinetics in a diverse population to inform MTXPK.org

Clinical and translational science, 2023-11, Vol.16 (11), p.2130-2143

2023

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and outcomes of pediatric oncology patients at risk for guardians declining transfusion of blood components

Cancer reports, 2023-01, Vol.6 (1), p.e1665-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

SARS‐CoV‐2 infections in patients enrolled on the Children's Oncology Group standard‐risk B‐cell acute lymphoblastic leukemia trial, AALL1731

EJHaem, 2023-08, Vol.4 (3), p.745-750

2023

Link zum Volltext

Verfügbarkeit prüfen

Improving symptom control and reducing toxicities for pediatric patients with hematological malignancies

Hematology, 2020-12, Vol.2020 (1), p.280-286

2020

Link zum Volltext

Verfügbarkeit prüfen

Adolescents and young adults (AYAs) vs pediatric patients: survival, risks, and barriers to enrollment

Hematology, 2023-12, Vol.2023 (1), p.581

2023

Link zum Volltext

Verfügbarkeit prüfen

Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: a report from the Children's Oncology Group

Haematologica (Roma), 2017-09, Vol.102 (9), p.e340

2017

Link zum Volltext

Verfügbarkeit prüfen

Evolution of Hematology Clinical Trial Adverse Event Reporting to Improve Care Delivery

Current hematologic malignancy reports, 2021-04, Vol.16 (2), p.126-131

2021

Link zum Volltext

Verfügbarkeit prüfen

Reply to H.S.L. Jim et al

Journal of clinical oncology, 2017-04, Vol.35 (10), p.1135-1135

2017

Link zum Volltext

Verfügbarkeit prüfen

Infectious events in pediatric patients with acute lymphoblastic leukemia/lymphoma undergoing evaluation for fever without severe neutropenia

Cancer, 2022-12, Vol.128 (23), p.4129-4138

2022

Link zum Volltext

Verfügbarkeit prüfen

Missing the mark? Exploratory analysis of the 10‐year‐old cutoff as an independent marker of high‐risk disease in pediatric B‐ALL

Pediatric blood & cancer, 2024-03, Vol.71 (3), p.e30825-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

High burden of clinically significant adverse events associated with contemporary therapy for pediatric T-cell acute lymphoblastic leukemia/lymphoma

Pediatric blood & cancer, 2023-11, Vol.70 (11), p.e30571-e30571

2023

Link zum Volltext

Verfügbarkeit prüfen

Acute and chronic kidney injury during therapy for pediatric acute leukemia: A report from the Leukemia Electronic Abstraction of Records Network (LEARN)

Pediatric blood & cancer, 2023-12, Vol.70 (12), p.e30696-e30696

2023

Link zum Volltext

Verfügbarkeit prüfen

Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials

JNCI : Journal of the National Cancer Institute, 2023-01, Vol.115 (1), p.21-28

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of respiratory viral panel testing on length of stay in pediatric cancer patients admitted with fever and neutropenia

Pediatric blood & cancer, 2020-11, Vol.67 (11), p.e28570-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Quantifying the difference in risk of adverse events by induction treatment regimen in pediatric acute lymphoblastic leukemia

Leukemia & lymphoma, 2021-03, Vol.62 (4), p.899-908

2021

Link zum Volltext

Verfügbarkeit prüfen

Preventable harm because of outpatient medication errors among children with leukemia and lymphoma: A multisite longitudinal assessment

Cancer, 2023-04, Vol.129 (7), p.1064-1074

2023

Link zum Volltext

Verfügbarkeit prüfen

Applying machine learning to identify pediatric patients with newly diagnosed acute lymphoblastic leukemia using administrative data

Pediatric blood & cancer, 2024-03, Vol.71 (3), p.e30858-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 210

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(192)
Mit Volltextzugriff
(185)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Unintended consequences of evolution of the Common Terminology Criteria for Adverse Events

Leveraging machine learning to identify acute myeloid leukemia patients and their chemotherapy regimens in an administrative database

Using electronic medical record data to report laboratory adverse events

A report from the Leukemia Electronic Abstraction of Records Network on risk of hepatotoxicity during pediatric acute lymphoblastic leukemia treatment

Data standards in pediatric oncology: Past, present, and future

Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemia

Supportive Care in Pediatric Oncology: Opportunities and Future Directions

An Interpretable Machine Learning Framework for Rare Disease: A Case Study to Stratify Infection Risk in Pediatric Leukemia

Clinical covariates that improve the description of high dose methotrexate pharmacokinetics in a diverse population to inform MTXPK.org

Characteristics and outcomes of pediatric oncology patients at risk for guardians declining transfusion of blood components

SARS‐CoV‐2 infections in patients enrolled on the Children's Oncology Group standard‐risk B‐cell acute lymphoblastic leukemia trial, AALL1731

Improving symptom control and reducing toxicities for pediatric patients with hematological malignancies

Adolescents and young adults (AYAs) vs pediatric patients: survival, risks, and barriers to enrollment

Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: a report from the Children's Oncology Group

Evolution of Hematology Clinical Trial Adverse Event Reporting to Improve Care Delivery

Reply to H.S.L. Jim et al

Infectious events in pediatric patients with acute lymphoblastic leukemia/lymphoma undergoing evaluation for fever without severe neutropenia

Missing the mark? Exploratory analysis of the 10‐year‐old cutoff as an independent marker of high‐risk disease in pediatric B‐ALL

High burden of clinically significant adverse events associated with contemporary therapy for pediatric T-cell acute lymphoblastic leukemia/lymphoma

Acute and chronic kidney injury during therapy for pediatric acute leukemia: A report from the Leukemia Electronic Abstraction of Records Network (LEARN)

Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials

Impact of respiratory viral panel testing on length of stay in pediatric cancer patients admitted with fever and neutropenia

Quantifying the difference in risk of adverse events by induction treatment regimen in pediatric acute lymphoblastic leukemia

Preventable harm because of outpatient medication errors among children with leukemia and lymphoma: A multisite longitudinal assessment

Applying machine learning to identify pediatric patients with newly diagnosed acute lymphoblastic leukemia using administrative data

Suchergebnisse filtern